Invesco Ltd. Buys 119,508 Shares of Avantor, Inc. $AVTR

Invesco Ltd. raised its stake in shares of Avantor, Inc. (NYSE:AVTR) by 0.8% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 16,053,368 shares of the company’s stock after purchasing an additional 119,508 shares during the period. Invesco Ltd.’s holdings in Avantor were worth $200,346,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also recently made changes to their positions in AVTR. EverSource Wealth Advisors LLC lifted its position in shares of Avantor by 119.1% in the second quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock worth $29,000 after buying an additional 1,189 shares in the last quarter. Strategic Wealth Investment Group LLC bought a new stake in Avantor in the 2nd quarter worth approximately $32,000. FNY Investment Advisers LLC purchased a new stake in shares of Avantor during the 2nd quarter worth approximately $36,000. Osaic Holdings Inc. raised its holdings in shares of Avantor by 60.9% during the 2nd quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock worth $38,000 after acquiring an additional 1,064 shares in the last quarter. Finally, Farther Finance Advisors LLC boosted its position in shares of Avantor by 172.1% during the 3rd quarter. Farther Finance Advisors LLC now owns 3,709 shares of the company’s stock valued at $46,000 after acquiring an additional 2,346 shares during the last quarter. 95.08% of the stock is owned by institutional investors.

Avantor Price Performance

Shares of AVTR stock opened at $9.19 on Monday. The stock has a 50 day moving average price of $11.38 and a 200 day moving average price of $12.20. Avantor, Inc. has a 52-week low of $8.90 and a 52-week high of $18.36. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.18 and a current ratio of 1.78. The firm has a market capitalization of $6.26 billion, a P/E ratio of -11.78, a P/E/G ratio of 3.62 and a beta of 0.94.

Avantor (NYSE:AVTR) last issued its earnings results on Wednesday, February 11th. The company reported $0.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.21 by $0.01. The firm had revenue of $1.66 billion during the quarter, compared to analyst estimates of $1.64 billion. Avantor had a negative net margin of 8.09% and a positive return on equity of 10.45%. The business’s revenue was down 1.4% on a year-over-year basis. During the same period in the previous year, the firm earned $0.27 earnings per share. Avantor has set its FY 2026 guidance at 0.770-0.830 EPS. As a group, sell-side analysts predict that Avantor, Inc. will post 1.06 earnings per share for the current year.

Insider Activity

In related news, Director Sanjeev K. Mehra purchased 350,000 shares of the firm’s stock in a transaction dated Friday, December 5th. The stock was purchased at an average price of $11.09 per share, with a total value of $3,881,500.00. Following the completion of the purchase, the director owned 350,000 shares of the company’s stock, valued at approximately $3,881,500. The trade was a ∞ increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Gregory L. Summe purchased 100,000 shares of the stock in a transaction that occurred on Thursday, February 12th. The stock was purchased at an average price of $9.40 per share, with a total value of $940,000.00. Following the acquisition, the director directly owned 400,000 shares of the company’s stock, valued at $3,760,000. This trade represents a 33.33% increase in their position. The SEC filing for this purchase provides additional information. 1.20% of the stock is owned by insiders.

Key Avantor News

Here are the key news stories impacting Avantor this week:

• Positive Sentiment: Director buys 100,000 shares — Long‑time director Gregory Summe purchased 100,000 shares at roughly $9.40, increasing his stake by ~33%, which can be read as management confidence and provides some near‑term support. Insider Purchase
• Positive Sentiment: Wells Fargo keeps an overweight rating (PT lowered to $14) — Analyst lowered the target from $16 to $14 but maintained an overweight stance, implying material upside from current levels and offering some buy-side rationale. Benzinga: Wells Fargo Note
• Neutral Sentiment: Q4 beat on adjusted EPS and revenue, but topline slipped year‑over‑year — Adjusted EPS of $0.22 beat consensus and revenue of $1.66B slightly topped estimates, yet sales declined y/y; mixed set that dampens enthusiasm despite the beat. Q4 Results
• Neutral Sentiment: Company roll‑out plan detailed — Management presented a “revival” program (VWR relaunch, supply‑chain and e‑commerce initiatives) and slide deck — important for execution but unlikely to reverse near‑term headwinds immediately. Slide Deck
• Negative Sentiment: FY2026 guidance misses consensus — Management set FY2026 EPS at $0.77–$0.83, below street expectations, which is the primary driver of the selloff as it signals continued margin and revenue pressure.
• Negative Sentiment: Market reaction and margin concerns — Analysts and media highlighted margin compression and declining organic sales; headlines noted the shares plunged after the report. Zacks: Stock Reaction
• Negative Sentiment: Heavy put option buying — Unusually large put volume (≈48k contracts) signals elevated bearish sentiment and hedging activity, increasing downside risk and volatility. Options Flow
• Negative Sentiment: GAAP profit swing to a net loss — The move to a 2025 GAAP net loss underscores near‑term execution risk despite adjusted profit metrics; investors will be watching execution on the recovery plan closely. Yahoo: Profit Swing

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the stock. Robert W. Baird set a $11.00 price target on shares of Avantor in a research report on Thursday. UBS Group reaffirmed a “neutral” rating and issued a $10.50 price target on shares of Avantor in a report on Thursday. TD Cowen reissued a “hold” rating on shares of Avantor in a research note on Thursday. Citigroup cut their target price on Avantor from $13.00 to $11.00 and set a “neutral” rating on the stock in a research report on Thursday. Finally, Bank of America downgraded Avantor from a “buy” rating to a “neutral” rating and set a $13.00 price target for the company. in a research report on Monday, December 15th. Three analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $11.84.

Avantor Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.